Summary
The influence of chronic treatment with clonidine on analgesia produced by clonidine and morphine was studied in rats. Electrical stimuli were applied to the tail, and analgesia was measured as increase in the threshold voltage that elicited vocalisation. Twentytwo hours after the last of 14 injections of increasing doses of clonidine over 7 days, the acute analgesic effects of both clonidine and morphine were reduced, i.e. tolerance had developed. Pretest vocalisation thresholds (voltage) were unchanged by long-term treatment with clonidine or, respectively, saline.
Contrarywise, acute administration of clonidine enhanced the effect of morphine. The tolerance developed after long-term treatment with clonidine might be associated with changes in brain noradrenaline mechanisms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bolme, P., Corrodi, H., Fuxe, K., Hökfelt, T., Lidbrink, P., Goldstein, M.: Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbine. Eur. J. Pharmacol. 28, 89–94 (1974)
Carroll, M. N., Lim, R. K. S.: Observations on the neuropharmacology of morphine and morphine-like analgesia. Arch. Int. Pharmacodyn. 125, 383–403 (1960)
Cicero, T. J.: Effects of alpha-adrenergic blocking agents on narcotic-induced analgesia. Arch. Int. Pharmacodyn. 208, 5–13 (1974)
Delbarre, B., Schmitt, H.: Sedative effects of α-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs. Eur. J. Pharmacol. 13, 356–363 (1971)
Hoefke, W., Kobinger, W.: Pharmakologische Wirkungen des 2-(2,6-Dichlorphenylamino)-2-imidazolin-Hydrochlorids, einer neuen, antihypertensiven Substanz. Arzneim.-Forsch. 16, 1038–1058 (1966)
Holman, R. B., Shillito, E. E., Vogt, M.: Sleep produced by clonidine 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride). Br. J. Pharmacol. 43, 685–695 (1971)
Korf, J., Bunney, B. S., Aghajanian, G. K.: Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur. J. Pharmacol. 25, 165–169 (1974)
Laverty, R., Taylor, K. M.: Behavioural and biochemical effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) on the central nervous system. Br. J. Pharmacol. 35, 253–264 (1969)
Meyer, D. R., El Azhary, R., Bierer, D. W. S., Hansen, S. K., Robbins, M. S., Sparber, S. B.: Tolerance and dependence after chronic administration of clonidine to the rat. Pharmacol. Biochem. Behaviour 7, 227–231 (1977)
Montel, H., Starke, K., Taube, H. D.: Influence of morphine and naloxone on the release of noradrenaline from rat cerebellar cortex slices. Naunyn-Schmiedeberg's Arch. Pharmacol. 288, 427–433 (1975)
Morpurgo, C.: Aggressive behaviour induced by large doses of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) in mice. Eur. J. Pharmacol. 3, 374–377 (1968)
Paalzow, L.: Analgesia produced by clonidine in mice and rats. J. Pharm. Pharmacol. 26, 361–363 (1974)
Paalzow, G.: The potential role of catecholamines in drug induced changes of central pain responses, with special emphasis on morphine effects in the rat. Doctoral Dissertation. Acta Universitatis Upsaliensis (1976)
Paalzow, G., Paalzow, L.: The effects of caffeine and theophylline on nociceptive stimulation in the rat. Acta Pharmacol. Toxicol. (Kbh.) 32, 22–32 (1973)
Paalzow, G., Paalzow, L.: Morphine-induced inhibition of different pain responses in relation to the regional turnover of rat brain noradrenaline and dopamine. Psychopharmacologia (Berl.) 45, 9–20 (1975)
Paalzow, G., Paalzow, L.: Clonidine antinociceptive activity: Effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 119–126 (1976a)
Paalzow, G., Paalzow, L.: Evaluation of the antinociceptive effects of 4,α-dimethyl-m-tyramine (H77/77) in the rat. Eur. J. Pharmacol. 36, 321–329 (1976b)
Paalzow, G., Paalzow, L.: Involvement of both pre- and postsynaptic catecholaminergic receptors in the mediation of analgesic activity — possible implications for morphine. In: Opiates and Endogenous Opoid Peptides (H. W. Kosterlitz, ed.), pp. 427–430. Amsterdam-New York-Oxford: North Holland Publ. Comp. 1976c
Price, M. T. C., Fibiger, H. C.: Ascending catecholamine systems and morphine analgesia. Brain Res. 99, 189–193 (1975)
Shuster, L.: In Narcotic Drugs Biochemical Pharmacology (D. H. Clouet, ed.), pp. 408–422. New York-London: Plenum Press 1971
Sokal, R. R., Rohlf, F. J.: Biometry. San Francisco: W. H. Freeman and Comp. 1969
Starke, K.: Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 77, 1–124 (1977)
Starke, K., Montel, H.: Involvement of α-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones. Neuropharmacology 12, 1073–1080 (1973)
Svensson, T. H., Strömbom, U.: Discontinuation of chronic clonidine treatment: Evidence for facilitated brain noradrenergic neurotransmission. Naunyn-Schmiedeberg's Arch. Pharmacol. 299, 83–87 (1977)
Svensson, T. H., Bunney, B. S., Aghajanian, G. K.: Inhibition of both noradrenergic and serotonergic neurons by the α-adrenergic agonist clonidine. Brain Res. 92, 291–306 (1975)
Tseng, L. F., Loh, H. H., Wei, E. T.: Effects of clonidine on morphine withdrawal signs in the rat. Eur. J. Pharmacol. 30, 93–99 (1975)
Vetulani, J., Bednarczyk, B.: Depression by clonidine of shaking behaviour elicited by nalorphine in morphine-dependent rats. J. Pharm. Pharmacol. 29, 567–568 (1977)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Paalzow, G. Development of tolerance to the analgesic effect of clonidine in rats cross-tolerance to morphine. Naunyn-Schmiedeberg's Arch. Pharmacol. 304, 1–4 (1978). https://doi.org/10.1007/BF00501369
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00501369